Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
The Lancet. Infectious Diseases|February 26, 2013
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trialMaryline Bonnet, Nilesh Bhatt, Elisabeth Baudin, et al.
Pathogens (Basel, Switzerland)|April 23, 2022
Diagnostic Advances in Childhood Tuberculosis-Improving Specimen Collection and Yield of Microbiological Diagnosis for Intrathoracic TuberculosisEric Wobudeya, Maryline Bonnet, Elisabetta Ghimenton Walters, et al.
Pediatrics|March 23, 2023
Mortality and Cause of Death in Children With Presumptive Disseminated TuberculosisMaryline Bonnet, Anne-Christine Nordholm, Bob Ssekyanzi, et al.
Emerging Infectious Diseases|June 20, 2017
Nontuberculous Mycobacteria Infections at a Provincial Reference Hospital, CambodiaMaryline Bonnet, Kim Chamroeun San, Yati Pho, et al.
Plos Medicine|April 6, 2019
Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort studyAnkur Gupta-Wright, Elizabeth L Corbett, Douglas Wilson, et al.
Eclinicalmedicine|July 15, 2024
Development of tuberculosis treatment decision algorithms in children below 5 years hospitalised with severe acute malnutrition in Zambia and Uganda: a prospective diagnostic cohort studyChishala Chabala, Clémentine Roucher, Minh Huyen Ton Nu Nguyet, et al.
Eclinicalmedicine|April 28, 2025
Treatment decision algorithms for tuberculosis screening and diagnosis in children below 5 years hospitalised with severe acute malnutrition: a cost-effectiveness analysisMarc d'Elbée, Nyashadzaishe Mafirakureva, Chishala Chabala, et al.
The Journal of Antimicrobial Chemotherapy|August 29, 2025
Pharmacokinetics of rifampicin and isoniazid in patients with HIV-tuberculosis coinfection receiving efavirenz-based antiretroviral treatment: an ANRS12292-RIFAVIRENZ sub-studyThibaut Gelé, Daniel Atwine, Elisabeth Baudin, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2020
Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug-drug interaction randomized trialDaniel Atwine, Elisabeth Baudin, Thibaut Gelé, et al.
Plos One|March 9, 2018
Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort studyMathieu Bastard, Elisabeth Sanchez-Padilla, Philipp du Cros, et al.
Pageof 11